Steven T. Plochocki, president and CEO, and Michael S. Madler, executive vice president, fixed-site division, resigned from InSight Health Services effective Aug. 9. Plochocki served the company for more than four years, and Madler was on board for
Steven T. Plochocki, president and CEO, and Michael S. Madler, executive vice president, fixed-site division, resigned from InSight Health Services effective Aug. 9. Plochocki served the company for more than four years, and Madler was on board for nearly eight. Michael N. Cannizzaro, Insight chairman of the board, has taken over as president and CEO. Cannizzaro is an operating partner of JW Childs Associates with 27 years of healthcare industry management experience. InSight provides diagnostic imaging and information, treatment, and related management services in 34 states. The company opened a new diagnostic imaging center in Columbus, OH, on Aug. 11, its third in the Columbus area.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
What if Radiology Turns Out Exactly the Way We Predict it Will?
May 19th 2025Whether it is reimbursement cuts or continued attempts to push non-radiologist image interpretation, where do we draw the line between inspired protest and misspent energy criticizing things that are doomed to fail or things we have no control over?
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
May 16th 2025For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.